NEW YORK (GenomeWeb News) – Rosetta Genomics said after the close of the market on Thursday it and Precision Therapeutics have amended their co-marketing deal entered into in July 2012 and revised in October.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.
A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.
Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.
Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."
In this online seminar, Jo Vandesompele of the Center for Medical Genetics at Ghent University will discuss methods for improving the analysis of microRNA expression from a range of samples.